nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLC22A7—Fluorouracil—skin cancer	0.167	0.567	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Docetaxel—skin cancer	0.127	0.433	CbGbCtD
Dinoprost Tromethamine—TBXA2R—endothelium—skin cancer	0.0146	0.0784	CbGeAlD
Dinoprost Tromethamine—TBXA2R—blood vessel—skin cancer	0.0135	0.0723	CbGeAlD
Dinoprost Tromethamine—GALR3—female reproductive system—skin cancer	0.00823	0.0442	CbGeAlD
Dinoprost Tromethamine—PTGIR—endothelium—skin cancer	0.00792	0.0426	CbGeAlD
Dinoprost Tromethamine—PTGIR—blood vessel—skin cancer	0.00731	0.0392	CbGeAlD
Dinoprost Tromethamine—Dinoprostone—PTGER4—skin cancer	0.0073	0.721	CrCbGaD
Dinoprost Tromethamine—GALR3—head—skin cancer	0.00688	0.0369	CbGeAlD
Dinoprost Tromethamine—TBXA2R—epithelium—skin cancer	0.00656	0.0352	CbGeAlD
Dinoprost Tromethamine—PTGFR—nipple—skin cancer	0.00599	0.0322	CbGeAlD
Dinoprost Tromethamine—Pregnancy—Imiquimod—skin cancer	0.00586	0.0262	CcSEcCtD
Dinoprost Tromethamine—PTGER3—connective tissue—skin cancer	0.00532	0.0286	CbGeAlD
Dinoprost Tromethamine—TBXA2R—female reproductive system—skin cancer	0.00487	0.0262	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—nipple—skin cancer	0.00466	0.025	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—nipple—skin cancer	0.00462	0.0248	CbGeAlD
Dinoprost Tromethamine—HPGDS—connective tissue—skin cancer	0.0046	0.0247	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—neck—skin cancer	0.00457	0.0245	CbGeAlD
Dinoprost Tromethamine—HPGDS—epithelium—skin cancer	0.00436	0.0234	CbGeAlD
Dinoprost Tromethamine—PTGER1—female reproductive system—skin cancer	0.00428	0.023	CbGeAlD
Dinoprost Tromethamine—Dehydration—Vismodegib—skin cancer	0.00426	0.019	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Vismodegib—skin cancer	0.00417	0.0186	CcSEcCtD
Dinoprost Tromethamine—HPGDS—mammalian vulva—skin cancer	0.00379	0.0203	CbGeAlD
Dinoprost Tromethamine—PTGER3—female reproductive system—skin cancer	0.00375	0.0201	CbGeAlD
Dinoprost Tromethamine—PTGIR—connective tissue—skin cancer	0.00375	0.0201	CbGeAlD
Dinoprost Tromethamine—Disseminated intravascular coagulation—Docetaxel—skin cancer	0.00371	0.0166	CcSEcCtD
Dinoprost Tromethamine—PTGER1—head—skin cancer	0.00357	0.0192	CbGeAlD
Dinoprost Tromethamine—PTGIR—epithelium—skin cancer	0.00356	0.0191	CbGeAlD
Dinoprost Tromethamine—HPGDS—lymphoid tissue—skin cancer	0.00336	0.018	CbGeAlD
Dinoprost Tromethamine—HPGDS—female reproductive system—skin cancer	0.00324	0.0174	CbGeAlD
Dinoprost Tromethamine—PTGER3—head—skin cancer	0.00313	0.0168	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—epithelium—skin cancer	0.00311	0.0167	CbGeAlD
Dinoprost Tromethamine—PTGFR—female reproductive system—skin cancer	0.003	0.0161	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—skin of body—skin cancer	0.00296	0.0159	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—skin cancer	0.00285	0.0153	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—skin cancer	0.00282	0.279	CrCbGaD
Dinoprost Tromethamine—SLCO3A1—mammalian vulva—skin cancer	0.00272	0.0146	CbGeAlD
Dinoprost Tromethamine—Extravasation—Bleomycin—skin cancer	0.00271	0.0121	CcSEcCtD
Dinoprost Tromethamine—HPGDS—head—skin cancer	0.00271	0.0145	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—mammalian vulva—skin cancer	0.0027	0.0145	CbGeAlD
Dinoprost Tromethamine—Back pain—Vismodegib—skin cancer	0.00267	0.0119	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Vismodegib—skin cancer	0.00265	0.0118	CcSEcCtD
Dinoprost Tromethamine—PTGIR—female reproductive system—skin cancer	0.00264	0.0142	CbGeAlD
Dinoprost Tromethamine—SLC22A11—female reproductive system—skin cancer	0.00258	0.0138	CbGeAlD
Dinoprost Tromethamine—Extravasation—Dactinomycin—skin cancer	0.00253	0.0113	CcSEcCtD
Dinoprost Tromethamine—PTGFR—head—skin cancer	0.0025	0.0135	CbGeAlD
Dinoprost Tromethamine—Petechiae—Temozolomide—skin cancer	0.00242	0.0108	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—female reproductive system—skin cancer	0.00233	0.0125	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female reproductive system—skin cancer	0.00231	0.0124	CbGeAlD
Dinoprost Tromethamine—PTGIR—head—skin cancer	0.00221	0.0119	CbGeAlD
Dinoprost Tromethamine—PTGER3—lymph node—skin cancer	0.00219	0.0118	CbGeAlD
Dinoprost Tromethamine—Extravasation—Fluorouracil—skin cancer	0.00211	0.00939	CcSEcCtD
Dinoprost Tromethamine—Respiratory failure—Temozolomide—skin cancer	0.00203	0.00906	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Temozolomide—skin cancer	0.00199	0.00889	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Bleomycin—skin cancer	0.00199	0.00888	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Imiquimod—skin cancer	0.00195	0.00871	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—head—skin cancer	0.00195	0.0105	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—head—skin cancer	0.00193	0.0104	CbGeAlD
Dinoprost Tromethamine—Pain—Vismodegib—skin cancer	0.00193	0.00859	CcSEcCtD
Dinoprost Tromethamine—Urinary incontinence—Temozolomide—skin cancer	0.00193	0.00859	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Dactinomycin—skin cancer	0.00191	0.00853	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Docetaxel—skin cancer	0.00191	0.00851	CcSEcCtD
Dinoprost Tromethamine—HPGDS—lymph node—skin cancer	0.0019	0.0102	CbGeAlD
Dinoprost Tromethamine—Phlebitis—Dactinomycin—skin cancer	0.00186	0.00829	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Vismodegib—skin cancer	0.00184	0.00822	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Imiquimod—skin cancer	0.00181	0.00807	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Vismodegib—skin cancer	0.00178	0.00795	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Vemurafenib—skin cancer	0.00178	0.00793	CcSEcCtD
Dinoprost Tromethamine—Chills—Vemurafenib—skin cancer	0.00176	0.00784	CcSEcCtD
Dinoprost Tromethamine—PTGFR—lymph node—skin cancer	0.00175	0.00942	CbGeAlD
Dinoprost Tromethamine—Thrombophlebitis—Temozolomide—skin cancer	0.00167	0.00746	CcSEcCtD
Dinoprost Tromethamine—Back pain—Vemurafenib—skin cancer	0.00165	0.00736	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vismodegib—skin cancer	0.00162	0.00721	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Fluorouracil—skin cancer	0.00159	0.00711	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Vismodegib—skin cancer	0.00159	0.00711	CcSEcCtD
Dinoprost Tromethamine—PTGIR—lymph node—skin cancer	0.00155	0.0083	CbGeAlD
Dinoprost Tromethamine—Diarrhoea—Vismodegib—skin cancer	0.00154	0.00688	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Fluorouracil—skin cancer	0.00154	0.00687	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Docetaxel—skin cancer	0.00152	0.00678	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Imiquimod—skin cancer	0.00152	0.00676	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Imiquimod—skin cancer	0.00151	0.00673	CcSEcCtD
Dinoprost Tromethamine—Chills—Imiquimod—skin cancer	0.0015	0.00669	CcSEcCtD
Dinoprost Tromethamine—Cough—Vemurafenib—skin cancer	0.00149	0.00664	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Bleomycin—skin cancer	0.00146	0.00651	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Temozolomide—skin cancer	0.00145	0.00646	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vismodegib—skin cancer	0.00143	0.00639	CcSEcCtD
Dinoprost Tromethamine—Rash—Vismodegib—skin cancer	0.00142	0.00634	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vismodegib—skin cancer	0.00142	0.00633	CcSEcCtD
Dinoprost Tromethamine—Back pain—Imiquimod—skin cancer	0.00141	0.00628	CcSEcCtD
Dinoprost Tromethamine—Infection—Vemurafenib—skin cancer	0.00138	0.00617	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—lymph node—skin cancer	0.00136	0.00733	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—skin cancer	0.00135	0.00726	CbGeAlD
Dinoprost Tromethamine—Respiratory failure—Docetaxel—skin cancer	0.00135	0.00602	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Imiquimod—skin cancer	0.00135	0.00602	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Temozolomide—skin cancer	0.00135	0.006	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vismodegib—skin cancer	0.00134	0.00597	CcSEcCtD
Dinoprost Tromethamine—Agitation—Imiquimod—skin cancer	0.00134	0.00596	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Docetaxel—skin cancer	0.00133	0.00592	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Temozolomide—skin cancer	0.00132	0.00588	CcSEcCtD
Dinoprost Tromethamine—Malaise—Imiquimod—skin cancer	0.00131	0.00585	CcSEcCtD
Dinoprost Tromethamine—Syncope—Imiquimod—skin cancer	0.0013	0.00582	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Vemurafenib—skin cancer	0.0013	0.0058	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Imiquimod—skin cancer	0.00128	0.0057	CcSEcCtD
Dinoprost Tromethamine—Cough—Imiquimod—skin cancer	0.00127	0.00566	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Fluorouracil—skin cancer	0.00127	0.00566	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Bleomycin—skin cancer	0.00126	0.00562	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Imiquimod—skin cancer	0.00126	0.00562	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Imiquimod—skin cancer	0.00126	0.0056	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Imiquimod—skin cancer	0.00124	0.00552	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Imiquimod—skin cancer	0.00122	0.00546	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—head—skin cancer	0.00121	0.00652	CbGeAlD
Dinoprost Tromethamine—Infection—Imiquimod—skin cancer	0.00118	0.00526	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Temozolomide—skin cancer	0.00117	0.00522	CcSEcCtD
Dinoprost Tromethamine—Shock—Imiquimod—skin cancer	0.00117	0.00521	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Imiquimod—skin cancer	0.00116	0.00517	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Docetaxel—skin cancer	0.00115	0.00513	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Imiquimod—skin cancer	0.00115	0.00512	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Docetaxel—skin cancer	0.00112	0.00498	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Docetaxel—skin cancer	0.00111	0.00496	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Vemurafenib—skin cancer	0.0011	0.00491	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Temozolomide—skin cancer	0.00108	0.00484	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Imiquimod—skin cancer	0.00107	0.00475	CcSEcCtD
Dinoprost Tromethamine—Chills—Bleomycin—skin cancer	0.00107	0.00475	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Docetaxel—skin cancer	0.00106	0.00473	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Imiquimod—skin cancer	0.00106	0.00472	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Imiquimod—skin cancer	0.00106	0.00471	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Vemurafenib—skin cancer	0.00103	0.00457	CcSEcCtD
Dinoprost Tromethamine—Pain—Imiquimod—skin cancer	0.00102	0.00453	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Fluorouracil—skin cancer	0.000999	0.00446	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vemurafenib—skin cancer	0.000999	0.00445	CcSEcCtD
Dinoprost Tromethamine—Chills—Dactinomycin—skin cancer	0.000993	0.00443	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Vemurafenib—skin cancer	0.000985	0.00439	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Imiquimod—skin cancer	0.000978	0.00436	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Imiquimod—skin cancer	0.000971	0.00433	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Fluorouracil—skin cancer	0.000969	0.00432	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Bleomycin—skin cancer	0.000959	0.00428	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Vemurafenib—skin cancer	0.000952	0.00425	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Imiquimod—skin cancer	0.000938	0.00419	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Imiquimod—skin cancer	0.000938	0.00419	CcSEcCtD
Dinoprost Tromethamine—Malaise—Bleomycin—skin cancer	0.000932	0.00416	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vemurafenib—skin cancer	0.00092	0.00411	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Temozolomide—skin cancer	0.000908	0.00405	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Temozolomide—skin cancer	0.000904	0.00403	CcSEcCtD
Dinoprost Tromethamine—Cough—Bleomycin—skin cancer	0.000902	0.00402	CcSEcCtD
Dinoprost Tromethamine—Chills—Temozolomide—skin cancer	0.000898	0.00401	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Docetaxel—skin cancer	0.000895	0.00399	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Dactinomycin—skin cancer	0.000894	0.00399	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Vemurafenib—skin cancer	0.000885	0.00395	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Bleomycin—skin cancer	0.00088	0.00392	CcSEcCtD
Dinoprost Tromethamine—Rash—Vemurafenib—skin cancer	0.000878	0.00392	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vemurafenib—skin cancer	0.000877	0.00391	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Imiquimod—skin cancer	0.000875	0.0039	CcSEcCtD
Dinoprost Tromethamine—Headache—Vemurafenib—skin cancer	0.000872	0.00389	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Bleomycin—skin cancer	0.000869	0.00388	CcSEcCtD
Dinoprost Tromethamine—Malaise—Dactinomycin—skin cancer	0.000869	0.00388	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Imiquimod—skin cancer	0.000852	0.0038	CcSEcCtD
Dinoprost Tromethamine—Back pain—Temozolomide—skin cancer	0.000843	0.00376	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Imiquimod—skin cancer	0.00084	0.00375	CcSEcCtD
Dinoprost Tromethamine—Infection—Bleomycin—skin cancer	0.000838	0.00374	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vemurafenib—skin cancer	0.000827	0.00369	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Docetaxel—skin cancer	0.000818	0.00365	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Imiquimod—skin cancer	0.000812	0.00362	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Dactinomycin—skin cancer	0.000811	0.00362	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Temozolomide—skin cancer	0.000809	0.00361	CcSEcCtD
Dinoprost Tromethamine—Agitation—Temozolomide—skin cancer	0.000801	0.00357	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Bleomycin—skin cancer	0.000788	0.00352	CcSEcCtD
Dinoprost Tromethamine—Malaise—Temozolomide—skin cancer	0.000786	0.00351	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Imiquimod—skin cancer	0.000785	0.0035	CcSEcCtD
Dinoprost Tromethamine—Infection—Dactinomycin—skin cancer	0.000781	0.00349	CcSEcCtD
Dinoprost Tromethamine—Cough—Temozolomide—skin cancer	0.000761	0.00339	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Bleomycin—skin cancer	0.000757	0.00338	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Temozolomide—skin cancer	0.000755	0.00337	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Imiquimod—skin cancer	0.000755	0.00337	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Temozolomide—skin cancer	0.000752	0.00336	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Bleomycin—skin cancer	0.000752	0.00335	CcSEcCtD
Dinoprost Tromethamine—Rash—Imiquimod—skin cancer	0.000748	0.00334	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Imiquimod—skin cancer	0.000748	0.00334	CcSEcCtD
Dinoprost Tromethamine—Headache—Imiquimod—skin cancer	0.000744	0.00332	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Temozolomide—skin cancer	0.000733	0.00327	CcSEcCtD
Dinoprost Tromethamine—Pain—Bleomycin—skin cancer	0.000721	0.00322	CcSEcCtD
Dinoprost Tromethamine—Infection—Temozolomide—skin cancer	0.000707	0.00315	CcSEcCtD
Dinoprost Tromethamine—Nausea—Imiquimod—skin cancer	0.000705	0.00315	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Docetaxel—skin cancer	0.0007	0.00312	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Fluorouracil—skin cancer	0.000696	0.0031	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Bleomycin—skin cancer	0.000695	0.0031	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Temozolomide—skin cancer	0.000688	0.00307	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Fluorouracil—skin cancer	0.000684	0.00305	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Fluorouracil—skin cancer	0.000675	0.00301	CcSEcCtD
Dinoprost Tromethamine—Pain—Dactinomycin—skin cancer	0.000673	0.003	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Bleomycin—skin cancer	0.000667	0.00297	CcSEcCtD
Dinoprost Tromethamine—Infection—Fluorouracil—skin cancer	0.000651	0.0029	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dactinomycin—skin cancer	0.000648	0.00289	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000643	0.00287	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00064	0.00224	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00064	0.00224	CbGpPWpGaD
Dinoprost Tromethamine—Tachycardia—Fluorouracil—skin cancer	0.00064	0.00285	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Temozolomide—skin cancer	0.000639	0.00285	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—MC1R—skin cancer	0.000637	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—MC1R—skin cancer	0.000635	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—MC1R—skin cancer	0.000635	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—Dyspnoea—Temozolomide—skin cancer	0.000634	0.00283	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—PTGER4—skin cancer	0.000632	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—Somnolence—Temozolomide—skin cancer	0.000632	0.00282	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dactinomycin—skin cancer	0.000622	0.00277	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dactinomycin—skin cancer	0.000622	0.00277	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Bleomycin—skin cancer	0.000621	0.00277	CcSEcCtD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000619	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—SHH—skin cancer	0.000618	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PTCH2—skin cancer	0.000616	0.00216	CbGpPWpGaD
Dinoprost Tromethamine—Hypotension—Fluorouracil—skin cancer	0.000612	0.00273	CcSEcCtD
Dinoprost Tromethamine—Pain—Temozolomide—skin cancer	0.000608	0.00271	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Bleomycin—skin cancer	0.000605	0.0027	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Docetaxel—skin cancer	0.000604	0.00269	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Docetaxel—skin cancer	0.000601	0.00268	CcSEcCtD
Dinoprost Tromethamine—Chills—Docetaxel—skin cancer	0.000597	0.00267	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Bleomycin—skin cancer	0.000597	0.00266	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Fluorouracil—skin cancer	0.000589	0.00263	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Temozolomide—skin cancer	0.000586	0.00261	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—SMO—skin cancer	0.000586	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—PTCH1—skin cancer	0.000586	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—Dyspnoea—Fluorouracil—skin cancer	0.000584	0.00261	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Fluorouracil—skin cancer	0.000583	0.0026	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Temozolomide—skin cancer	0.000582	0.00259	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Dactinomycin—skin cancer	0.000579	0.00258	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—PTGER4—skin cancer	0.00057	0.002	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Dactinomycin—skin cancer	0.000564	0.00252	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Temozolomide—skin cancer	0.000562	0.00251	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Temozolomide—skin cancer	0.000562	0.00251	CcSEcCtD
Dinoprost Tromethamine—Back pain—Docetaxel—skin cancer	0.000561	0.0025	CcSEcCtD
Dinoprost Tromethamine—Pain—Fluorouracil—skin cancer	0.00056	0.0025	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00056	0.00196	CbGpPWpGaD
Dinoprost Tromethamine—Muscle spasms—Docetaxel—skin cancer	0.000557	0.00249	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RHOU—skin cancer	0.000557	0.00195	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—TP53—skin cancer	0.000551	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000548	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000548	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RHOU—skin cancer	0.000545	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RHOU—skin cancer	0.000545	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—MC1R—skin cancer	0.000544	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Fluorouracil—skin cancer	0.00054	0.00241	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dactinomycin—skin cancer	0.000538	0.0024	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Bleomycin—skin cancer	0.000536	0.00239	CcSEcCtD
Dinoprost Tromethamine—Rash—Bleomycin—skin cancer	0.000532	0.00237	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Bleomycin—skin cancer	0.000531	0.00237	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Temozolomide—skin cancer	0.000524	0.00234	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTCH2—skin cancer	0.00052	0.00182	CbGpPWpGaD
Dinoprost Tromethamine—Syncope—Docetaxel—skin cancer	0.00052	0.00232	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Fluorouracil—skin cancer	0.000518	0.00231	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000516	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Temozolomide—skin cancer	0.00051	0.00228	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.00051	0.00179	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Docetaxel—skin cancer	0.000509	0.00227	CcSEcCtD
Dinoprost Tromethamine—Cough—Docetaxel—skin cancer	0.000506	0.00226	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Temozolomide—skin cancer	0.000503	0.00225	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Docetaxel—skin cancer	0.000502	0.00224	CcSEcCtD
Dinoprost Tromethamine—Nausea—Bleomycin—skin cancer	0.000501	0.00223	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Docetaxel—skin cancer	0.0005	0.00223	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dactinomycin—skin cancer	0.0005	0.00223	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—PLIN2—skin cancer	0.000497	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Dactinomycin—skin cancer	0.000496	0.00221	CcSEcCtD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000494	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—MC1R—skin cancer	0.000494	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—Chest pain—Docetaxel—skin cancer	0.000493	0.0022	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—MC1R—skin cancer	0.00049	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Temozolomide—skin cancer	0.000487	0.00217	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Fluorouracil—skin cancer	0.000483	0.00215	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Temozolomide—skin cancer	0.00047	0.0021	CcSEcCtD
Dinoprost Tromethamine—Infection—Docetaxel—skin cancer	0.00047	0.0021	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dactinomycin—skin cancer	0.000467	0.00208	CcSEcCtD
Dinoprost Tromethamine—Shock—Docetaxel—skin cancer	0.000465	0.00208	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Fluorouracil—skin cancer	0.000464	0.00207	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—SHH—skin cancer	0.000462	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—Tachycardia—Docetaxel—skin cancer	0.000462	0.00206	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—PTGER4—skin cancer	0.000461	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PTCH2—skin cancer	0.00046	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—SHH—skin cancer	0.000454	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—SHH—skin cancer	0.000452	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—SHH—skin cancer	0.000452	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Temozolomide—skin cancer	0.000452	0.00202	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PTCH2—skin cancer	0.000451	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PTCH2—skin cancer	0.000451	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Temozolomide—skin cancer	0.000449	0.002	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Fluorouracil—skin cancer	0.000448	0.002	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000448	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—Dermatitis—Temozolomide—skin cancer	0.000448	0.002	CcSEcCtD
Dinoprost Tromethamine—Headache—Temozolomide—skin cancer	0.000446	0.00199	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MC1R—skin cancer	0.000445	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—Hypotension—Docetaxel—skin cancer	0.000442	0.00197	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—PTCH1—skin cancer	0.000438	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—SMO—skin cancer	0.000438	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Fluorouracil—skin cancer	0.000433	0.00193	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—SMO—skin cancer	0.00043	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PTCH1—skin cancer	0.00043	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—SMO—skin cancer	0.000429	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—PTCH1—skin cancer	0.000429	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—SMO—skin cancer	0.000429	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—PTCH1—skin cancer	0.000429	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—PTGER4—skin cancer	0.000427	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Docetaxel—skin cancer	0.000425	0.00189	CcSEcCtD
Dinoprost Tromethamine—Nausea—Temozolomide—skin cancer	0.000423	0.00188	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Docetaxel—skin cancer	0.000422	0.00188	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Docetaxel—skin cancer	0.000421	0.00188	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PTGER4—skin cancer	0.000419	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—PTGER4—skin cancer	0.000418	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—PTGER4—skin cancer	0.000418	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Fluorouracil—skin cancer	0.000417	0.00186	CcSEcCtD
Dinoprost Tromethamine—Rash—Fluorouracil—skin cancer	0.000413	0.00184	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Fluorouracil—skin cancer	0.000413	0.00184	CcSEcCtD
Dinoprost Tromethamine—Headache—Fluorouracil—skin cancer	0.000411	0.00183	CcSEcCtD
Dinoprost Tromethamine—Pain—Docetaxel—skin cancer	0.000405	0.0018	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTCH2—skin cancer	0.000403	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CSPG4—skin cancer	0.000401	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GLI2—skin cancer	0.000394	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Docetaxel—skin cancer	0.00039	0.00174	CcSEcCtD
Dinoprost Tromethamine—Nausea—Fluorouracil—skin cancer	0.000389	0.00174	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Docetaxel—skin cancer	0.000387	0.00173	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000377	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MC1R—skin cancer	0.000376	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—Abdominal pain—Docetaxel—skin cancer	0.000374	0.00167	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Docetaxel—skin cancer	0.000374	0.00167	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GLI1—skin cancer	0.000371	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—MC1R—skin cancer	0.000367	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTCH2—skin cancer	0.000364	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—MC1R—skin cancer	0.000359	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—MC1R—skin cancer	0.000359	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—PTGER4—skin cancer	0.000357	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—SHH—skin cancer	0.000352	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SUFU—skin cancer	0.000351	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Docetaxel—skin cancer	0.000349	0.00155	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000342	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Docetaxel—skin cancer	0.000339	0.00151	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Docetaxel—skin cancer	0.000335	0.00149	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—SMO—skin cancer	0.000333	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PTCH1—skin cancer	0.000333	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MC1R—skin cancer	0.000333	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000329	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MC1R—skin cancer	0.000326	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MC1R—skin cancer	0.000326	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PTGER4—skin cancer	0.000325	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Docetaxel—skin cancer	0.000324	0.00144	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—PTGER4—skin cancer	0.000322	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—SHH—skin cancer	0.000317	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000314	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Docetaxel—skin cancer	0.000313	0.0014	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GLI2—skin cancer	0.000306	0.00107	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000304	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Docetaxel—skin cancer	0.000301	0.00134	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—SMO—skin cancer	0.000301	0.00105	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PTCH1—skin cancer	0.000301	0.00105	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Docetaxel—skin cancer	0.000298	0.00133	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Docetaxel—skin cancer	0.000298	0.00133	CcSEcCtD
Dinoprost Tromethamine—Headache—Docetaxel—skin cancer	0.000296	0.00132	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PTGER4—skin cancer	0.000293	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MC1R—skin cancer	0.000292	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GLI1—skin cancer	0.000287	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000283	0.000994	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Docetaxel—skin cancer	0.000281	0.00125	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GLI2—skin cancer	0.000276	0.000966	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ENO2—skin cancer	0.000272	0.000955	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SUFU—skin cancer	0.000272	0.000955	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTCH2—skin cancer	0.000272	0.000954	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SHH—skin cancer	0.000268	0.000939	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTCH2—skin cancer	0.000266	0.000933	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RASA1—skin cancer	0.000266	0.000933	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTCH2—skin cancer	0.000266	0.000933	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MC1R—skin cancer	0.000263	0.000922	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000262	0.000919	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GLI1—skin cancer	0.000259	0.000909	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTCH1—skin cancer	0.000254	0.00089	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SMO—skin cancer	0.000254	0.00089	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTGER4—skin cancer	0.000247	0.000867	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SUFU—skin cancer	0.000246	0.000861	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PTGER4—skin cancer	0.000241	0.000845	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000241	0.000845	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—SHH—skin cancer	0.000237	0.000832	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PTGER4—skin cancer	0.000236	0.000827	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PTGER4—skin cancer	0.000236	0.000827	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—SHH—skin cancer	0.000232	0.000814	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—SHH—skin cancer	0.000232	0.000814	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000231	0.000808	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PTCH1—skin cancer	0.000225	0.000788	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—SMO—skin cancer	0.000225	0.000788	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000222	0.000779	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—SMO—skin cancer	0.00022	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PTCH1—skin cancer	0.00022	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—SMO—skin cancer	0.00022	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PTCH1—skin cancer	0.00022	0.000772	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PTGER4—skin cancer	0.000219	0.000767	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FOXO4—skin cancer	0.000218	0.000766	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000217	0.000762	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PTGER4—skin cancer	0.000214	0.000751	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PTGER4—skin cancer	0.000214	0.000751	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000213	0.000747	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SHH—skin cancer	0.000208	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RASA1—skin cancer	0.000206	0.000724	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GLI2—skin cancer	0.000206	0.000723	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GLI2—skin cancer	0.000202	0.000707	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GLI2—skin cancer	0.000202	0.000707	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SMO—skin cancer	0.000197	0.00069	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTCH1—skin cancer	0.000197	0.00069	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MC1R—skin cancer	0.000197	0.000689	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GLI1—skin cancer	0.000194	0.000679	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MC1R—skin cancer	0.000193	0.000675	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MC1R—skin cancer	0.000193	0.000675	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTGER4—skin cancer	0.000192	0.000672	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000191	0.00067	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GLI1—skin cancer	0.00019	0.000665	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GLI1—skin cancer	0.00019	0.000665	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SHH—skin cancer	0.000187	0.000657	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000187	0.000656	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RASA1—skin cancer	0.000186	0.000653	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SUFU—skin cancer	0.000184	0.000644	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SUFU—skin cancer	0.00018	0.00063	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SUFU—skin cancer	0.00018	0.00063	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTCH1—skin cancer	0.000178	0.000623	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SMO—skin cancer	0.000178	0.000623	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTGER4—skin cancer	0.000173	0.000606	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FOXO4—skin cancer	0.000169	0.000594	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—NRAS—skin cancer	0.000166	0.000582	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000163	0.00057	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000159	0.000558	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	0.000159	0.000556	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ERCC2—skin cancer	0.000158	0.000555	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000156	0.000545	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FOXO4—skin cancer	0.000153	0.000536	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000152	0.000534	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TERT—skin cancer	0.000146	0.000511	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—KRAS—skin cancer	0.000143	0.000501	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SHH—skin cancer	0.00014	0.000491	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RASA1—skin cancer	0.000139	0.000488	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SHH—skin cancer	0.000137	0.000481	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SHH—skin cancer	0.000137	0.000481	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RASA1—skin cancer	0.000136	0.000478	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RASA1—skin cancer	0.000136	0.000478	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTCH1—skin cancer	0.000133	0.000466	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SMO—skin cancer	0.000133	0.000466	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTCH1—skin cancer	0.00013	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SMO—skin cancer	0.00013	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTCH1—skin cancer	0.00013	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SMO—skin cancer	0.00013	0.000456	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLIN2—skin cancer	0.00013	0.000454	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTGER4—skin cancer	0.000129	0.000453	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—skin cancer	0.000127	0.000445	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTGER4—skin cancer	0.000127	0.000444	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTGER4—skin cancer	0.000127	0.000444	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—NRAS—skin cancer	0.000123	0.000431	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—BRAF—skin cancer	0.000122	0.000426	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—HRAS—skin cancer	0.000121	0.000426	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—BRAF—skin cancer	0.000116	0.000405	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FOXO4—skin cancer	0.000114	0.0004	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TERT—skin cancer	0.000113	0.000397	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FOXO4—skin cancer	0.000112	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FOXO4—skin cancer	0.000112	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—NRAS—skin cancer	0.00011	0.000384	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—KRAS—skin cancer	0.000106	0.000371	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CSPG4—skin cancer	0.000104	0.000366	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TERT—skin cancer	0.000102	0.000358	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—NRAS—skin cancer	9.53e-05	0.000334	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—skin cancer	9.49e-05	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—KRAS—skin cancer	9.44e-05	0.000331	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—HRAS—skin cancer	8.99e-05	0.000315	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—BRAF—skin cancer	8.96e-05	0.000314	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL6—skin cancer	8.61e-05	0.000302	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—NRAS—skin cancer	8.6e-05	0.000301	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—skin cancer	8.39e-05	0.000294	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—KRAS—skin cancer	8.2e-05	0.000288	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—BRAF—skin cancer	8.08e-05	0.000283	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—HRAS—skin cancer	8.02e-05	0.000281	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TERT—skin cancer	7.63e-05	0.000267	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TERT—skin cancer	7.47e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TERT—skin cancer	7.47e-05	0.000262	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—KRAS—skin cancer	7.4e-05	0.000259	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	7.29e-05	0.000256	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NRAS—skin cancer	7.26e-05	0.000255	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ENO2—skin cancer	7.1e-05	0.000249	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—HRAS—skin cancer	6.97e-05	0.000244	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—skin cancer	6.67e-05	0.000234	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—skin cancer	6.43e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—NRAS—skin cancer	6.29e-05	0.000221	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—skin cancer	6.29e-05	0.000221	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—HRAS—skin cancer	6.29e-05	0.00022	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KRAS—skin cancer	6.25e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—BRAF—skin cancer	6.04e-05	0.000212	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—skin cancer	6.02e-05	0.000211	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—BRAF—skin cancer	5.91e-05	0.000207	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—BRAF—skin cancer	5.91e-05	0.000207	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NRAS—skin cancer	5.63e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—HRAS—skin cancer	5.59e-05	0.000196	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—skin cancer	5.55e-05	0.000195	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—KRAS—skin cancer	5.53e-05	0.000194	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—KRAS—skin cancer	5.42e-05	0.00019	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—KRAS—skin cancer	5.42e-05	0.00019	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—HRAS—skin cancer	5.31e-05	0.000186	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—skin cancer	5.08e-05	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NRAS—skin cancer	5.08e-05	0.000178	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KRAS—skin cancer	4.85e-05	0.00017	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—skin cancer	4.7e-05	0.000165	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—skin cancer	4.6e-05	0.000161	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—HRAS—skin cancer	4.6e-05	0.000161	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—skin cancer	4.5e-05	0.000158	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—skin cancer	4.41e-05	0.000154	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—skin cancer	4.41e-05	0.000154	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KRAS—skin cancer	4.37e-05	0.000153	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—skin cancer	4.31e-05	0.000151	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ERCC2—skin cancer	4.12e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—HRAS—skin cancer	4.12e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—skin cancer	3.94e-05	0.000138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—skin cancer	3.88e-05	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NRAS—skin cancer	3.8e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NRAS—skin cancer	3.72e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NRAS—skin cancer	3.72e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—HRAS—skin cancer	3.72e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—skin cancer	3.56e-05	0.000125	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KRAS—skin cancer	3.27e-05	0.000115	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KRAS—skin cancer	3.2e-05	0.000112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KRAS—skin cancer	3.2e-05	0.000112	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—skin cancer	2.9e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—skin cancer	2.84e-05	9.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—skin cancer	2.84e-05	9.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—HRAS—skin cancer	2.78e-05	9.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—HRAS—skin cancer	2.72e-05	9.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—HRAS—skin cancer	2.72e-05	9.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—skin cancer	2.66e-05	9.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—skin cancer	2.6e-05	9.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—skin cancer	2.6e-05	9.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—skin cancer	2.47e-05	8.66e-05	CbGpPWpGaD
